SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Joe Copia's daytrades/investments and thoughts -- Ignore unavailable to you. Want to Upgrade?


To: Joe Copia who wrote (1369)4/30/1998 10:38:00 AM
From: TARIQ STOCKS  Read Replies (2) | Respond to of 25711
 
Joe, The scope on HEMA,

Notice in the last press release regarding the delisting threat and I quote:
" The company is presently assessing the options available to achieve compliance with the rule and INTENDS TO RETAIN ITS NASDAQ LISTING. "

To do so they need the price of the stock to exceed $1 for a minimum of 10 days. This is from a healthy and profitable company with a lot of cash???

They have three options:
1- reverse split: it is too late for this option.
2- big anouncements under thier sleeves: maybe.
3- A buy back of shares: most likely.

Therefore we are sure to see the dollar and more.
Exact same scenario with BITI which was also threatend by delisting and they promissed to do some thing about it. Study BITI carefully and you will see the similarities, infact HEMA has even better inancial numbers. BITI is expected to get another jump start really soon to stay above the $1. Though HEMA in the long haul is sure to be at the $5 range because of the impressive numbers, soon it will jump %100 and more to stay NASDAQ.

In my humble view, a sure winner.
Homepage: hemacare.com